Excelsior Medical Co., Ltd. Statistics
Excelsior Medical Co., Ltd. (4104) Stock Statistics & Valuation Metrics
Total Valuation
Excelsior Medical Co., Ltd. has a market cap or net worth of TWD 13.52B. The enterprise value is TWD 14.17B.
- Market Cap
- TWD 13.52B
- Enterprise Value
- TWD 14.17B
Share Statistics
Excelsior Medical Co., Ltd. has 188,367,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 188,367,460
- Owned by Insiders
- ―
- Owned by Institutions
- 0.40%
Financial Efficiency
Excelsior Medical Co., Ltd.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 4.23%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 4.23%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 11.36M
- Profits Per Employee
- 1.04M
- Employee Count
- 774
- Asset Turnover
- 0.46
- Inventory Turnover
- 4.97
Valuation Ratios
The current PE Ratio of Excelsior Medical Co., Ltd. is 14.60. Excelsior Medical Co., Ltd.’s PEG ratio is 2.10.
- PE Ratio
- 14.60
- PS Ratio
- 1.47
- PB Ratio
- 1.54
- Price to FCF
- 32.22
- Price to Operating Cash Flow
- 29.00
- PEG Ratio
- 2.10
Income Statement
In the last 12 months, Excelsior Medical Co., Ltd. had revenue of 8.79B and earned 805.86M in profits. Earnings per share was 4.62.
- Revenue
- 8.79B
- Gross Profit
- 1.87B
- Operating Income
- 739.84M
- Pretax Income
- 1.18B
- Net Income
- 805.86M
- EBITDA
- 1.04B
- Earnings Per Share (EPS)
- 4.62
Cash Flow
In the last 12 months, operating cash flow was 520.04M and capital expenditures -99.15M, giving a free cash flow of 420.88M billion.
- Operating Cash Flow
- 520.04M
- Free Cash Flow
- 420.88M
- Free Cash Flow per Share
- 2.01
Dividends & Yields
Excelsior Medical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.99%
- Dividend Per Share
- ―
- Dividend Yield
- 5.99%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.10%
- Earnings Yield
- 5.93%
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- -14.51%
- 50-Day Moving Average
- 72.39
- 200-Day Moving Average
- 71.73
- Relative Strength Index (RSI)
- 39.50
- Average Volume (3m)
- 152.35K
Important Dates
Excelsior Medical Co., Ltd. upcoming earnings date is Mar 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 05, 2027
- Ex-Dividend Date
- ―
Financial Position
Excelsior Medical Co., Ltd. as a current ratio of 1.67, with Debt / Equity ratio of 23.50%
- Current Ratio
- 1.67
- Quick Ratio
- 1.45
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- -0.66
- Interest Coverage Ratio
- 21.19
Taxes
In the past 12 months, Excelsior Medical Co., Ltd. has paid 216.30M in taxes.
- Income Tax
- 216.30M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Excelsior Medical Co., Ltd. EV to EBITDA ratio is 11.03, with an EV/FCF ratio of 30.02.
- EV to Sales
- 1.37
- EV to EBITDA
- 11.03
- EV to Free Cash Flow
- 30.02
- EV to Operating Cash Flow
- 24.30
Balance Sheet
Excelsior Medical Co., Ltd. has TWD 4.43B in cash and marketable securities with TWD 2.41B in debt, giving a net cash position of TWD 2.02B billion.
- Cash & Marketable Securities
- TWD 4.43B
- Total Debt
- TWD 2.41B
- Net Cash
- TWD 2.02B
- Net Cash Per Share
- TWD 10.71
- Tangible Book Value Per Share
- TWD 62.00
Margins
Gross margin is 21.34%, with operating margin of 7.87%, and net profit margin of 9.72%.
- Gross Margin
- 21.34%
- Operating Margin
- 7.87%
- Pretax Margin
- 13.74%
- Net Profit Margin
- 9.72%
- EBITDA Margin
- 12.44%
- EBIT Margin
- 8.94%
Analyst Forecast
The average price target for Excelsior Medical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.09%
- EPS Growth Forecast
- 7.11%
